资讯
3 天
TipRanks on MSNSanofi’s Phase 3 Study on Riliprubart for CIDP: A Potential Game-Changer
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...
5 天
India Today NE on MSNTripura doctors restore mobility of 60-year-old patient with rare neurological therapy
A 60-year-old man regains mobility after advanced treatment. AGMC and GB Pant Hospital in Tripura mark a milestone in ...
We came across a bullish thesis on argenx SE on Stock Analysis Compilation. In this article, we will summarize the bulls’ ...
Roivant Sciences Ltd.'s Vant model offers risk-isolated growth and monetization flexibility. Click for key ROIV drivers ...
After years of unexplained pain in her joints, nerves, and stomach, this writer finally found some relief—and a new community ...
Remegen's Telitacicept met its primary endpoints in a Chinese trial, while a US-based Phase III trial in Sjögren's syndrome ...
Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.
IMVT reports a narrower Q1 loss, as spotlight remains on IMVT-1402's broad clinical potential across multiple indications.
Argenx has found a new doubles partner for its work to raise awareness of myasthenia gravis (MG). | Argenx has found a new doubles partner for its work to raise awareness of myasthenia gravis.
Objective Increasing evidence supports reciprocal communication between the enteric and the central nervous system in disease, termed the ‘gut–brain axis’. Recent findings suggest a connection between ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果